Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inari Medical, Inc. - Common Stock (NQ: NARI )

79.74 +0.28 (+0.35%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Inari Medical, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Inari Medical Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders. 
Via Benzinga
Why Shares of Inari Medical Are Up Thursday
The company announced second-quarter earnings. 
Via The Motley Fool
Looking Into Inari Medical's Return On Invested Capital
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
2 Top Healthcare Stocks I'd Buy Now Without Hesitation
Whether you're seeking dividends or explosive growth, the economy's most reliable sector has something for you. 
Via The Motley Fool
Inari Medical Stock Gained 21% on Thursday - Here's Why It Soared
Inari Medical Inc (NASDAQ: NARI) shares gained on Thursday after the company reported Q2 revenues of $119.0 million, up 28.3% Y/Y, beating the  
Via Benzinga
Clorox, Boot Barn, Herbalife, Upwork And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones falling around 100 points on Thursday. Here are some big stocks recording gains in today’s session. Traeger, Inc. (NYSE: COOK) shares jumped 43.2% to $5.90... 
Via Benzinga
Analyst Expectations for Inari Medical's Future
Via Benzinga
Inari Medical: Q1 Earnings Insights
Via Benzinga
Why Shares of Inari Medical Rose This Week
The medical equipment maker's stock has climbed by $10 a share since the start of the month. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
3 Magnificent Growth Stocks With 38% to 64% Upside Potential, According to Wall Street
Find out why the investment bankers who follow these stocks think they can soar in the near term. 
Via The Motley Fool
Analyst Expectations for Inari Medical's Future
Via Benzinga
What 6 Analyst Ratings Have To Say About Inari Medical
Via Benzinga
Analyst Ratings for Inari Medical
Analysts have provided the following ratings for Inari Medical (NASDAQ:NARI) within the last quarter: 
Via Benzinga
Where Inari Medical Stands With Analysts
Analysts have provided the following ratings for Inari Medical (NASDAQ:NARI) within the last quarter: 
Via Benzinga
Earnings Scheduled For February 27, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. 
Via Benzinga
Inari Medical Earnings Preview
Via Benzinga
Analyst Ratings for Inari Medical
Via Benzinga
3 Beaten-Down Growth Stocks That I'm Loading Up On in 2023
These stocks are all down by at least 42% from their all-time highs despite impressive performances from their underlying businesses. 
Via The Motley Fool
3 Remarkable Growth Stocks That Could Climb 39% to 46%, According to Wall Street
These companies are reporting financial results that aren't being reflected in their stock market performances. 
Via The Motley Fool
2 Top Growth Stocks Down 42.6% and 68.5% to Buy Before They Rebound in 2023
These relatively reliable healthcare businesses are performing much better than their beaten-down stock prices would suggest. 
Via The Motley Fool
Where Inari Medical Stands With Analysts
Over the past 3 months, 6 analysts have published their opinion on Inari Medical (NASDAQ:NARI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022
Upgrades See all analyst ratings upgrades. 
Via Benzinga
Morgan Stanley Maintains Overweight Rating for Inari Medical: Here's What You Need To Know
Morgan Stanley has decided to maintain its Overweight rating of Inari Medical (NASDAQ:NARI) and lower its price target from $108.00 to $93.00. Shares of Inari Medical are trading up 0.74% over the last... 
Via Benzinga
Inari Medical's Return On Capital Employed Insights
Benzinga Pro data, Inari Medical (NASDAQ:NARI) reported Q1 sales of $86.75 million. Earnings fell to a loss of $3.13 million, resulting in a 382.66% decrease from last quarter. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2022
Upgrades 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.